For the Inventor, By the Inventor

Enter assignee name

San Antonio, TX, United States of America

Celonova Biosciences, Inc.

USPTO Granted Patents = 16

CIPO Patents = 12

EPO Patents = 7

Trademarks = 4

Forward Citations = 57

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Michael Lee (6 out of 40 patents)

Richard L Klein (4 out of 11 patents)

Ulf Fritz (3 out of 10 patents)

4. Riley King (3 out of 3 patents)

5. John Birtles (3 out of 3 patents)

6. John Koos (3 out of 3 patents)

7. Olaf Fritz (2 out of 9 patents)

8. Kent C B Stalker (2 out of 45 patents)

9. James Clayton Peacock, Iii (2 out of 48 patents)

10. Ronald Wojcik (2 out of 5 patents)

11. Thomas A Gordy (2 out of 7 patents)

12. Stuart Earl Kari (2 out of 12 patents)

13. Mark C Bates (2 out of 36 patents)

14. Jacques Blümmel (2 out of 4 patents)

15. Alexander Küller (2 out of 5 patents)

16 patents: Sort by Forward Citations

1. 10881540 - Implantable and lumen-supporting stents and related methods of manufacture and use (2021-01-05),

2. 10327926 - Implantable and lumen-supporting stents and related methods of manufacture and use (2019-06-25),

3. 10285968 - Drug eluting expandable devices (2019-05-14),

4. 9949944 - Drug eluting expandable devices (2018-04-24),

5. 9717608 - Expandable devices (2017-08-01),

6. 9445927 - Implantable and lumen-supporting stents and related methods of manufacture and use (2016-09-20),

7. 9358139 - Expandable devices (2016-06-07),

8. 9114162 - Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same (2015-08-25),

9. 9114125 - Drug eluting expandable devices (2015-08-25),

10. 9107850 - Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same (2015-08-18),

11. 9080146 - Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface (2015-07-14),

12. 8541014 - Gamma-tocopherol therapy for restenosis prevention (2013-09-24),

13. 8101275 - Device based on nitinol, a process for its production, and its use (2012-01-24),

14. 8101199 - Des-methyl-tocopherol therapy for restenosis prevention (2012-01-24),

15. 8097269 - Bioactive material delivery systems comprising sol-gel compositions (2012-01-17),

CeloNova BioSciences, Inc. is a global medical device company that develops, manufactures, and markets innovative interventional cardiology and radiology solutions. They are dedicated to improving patient outcomes and providing healthcare professionals with advanced technologies. With a focus on developing next-generation solutions, CeloNova BioSciences aims to revolutionize the field of interventional medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

16 Patents

#40 in San Antonio, TX

#1,192 in Texas

#19,264 in US

#36,617 in the World

San Antonio, TX, United States of America

Celonova Biosciences, Inc.

Forward Citations = 57

35 inventors:

Michael Lee (6 out of 40 patents)

Richard L Klein (4 out of 11 patents)

Ulf Fritz (3 out of 10 patents)

4. Riley King (3 out of 3 patents)

5. John Birtles (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…